NEOPLASMS PANCREATIC
Clinical trials for NEOPLASMS PANCREATIC explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS PANCREATIC trials appear
Sign up with your email to follow new studies for NEOPLASMS PANCREATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets tough cancers in Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called 9-ING-41, which blocks a protein (GSK-3β) that helps cancers grow. It is given alone or with chemotherapy to 350 adults with advanced or hard-to-treat cancers like pancreatic, breast, lung, or bone cancer. The goal is to see if the dru…
Matched conditions: NEOPLASMS PANCREATIC
Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 05:44 UTC
-
New hope for pancreatic cancer: drug combo trial underway
Disease control OngoingThis study tests whether adding two experimental drugs (avutometinib and defactinib) to standard chemotherapy can help people with advanced pancreatic cancer that has spread. About 40 adults with untreated metastatic pancreatic cancer will take part. The goal is to see if the com…
Matched conditions: NEOPLASMS PANCREATIC
Phase: PHASE1, PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC